CoChat

Update in Cardiac Sarcoidosis

Ribeiro Neto, Manuel L., Jellis, Christine L., Joyce, Emer, Callahan, Thomas D., Hachamovitch, Rory, Culver, Daniel A. · 2019 · Annals of the American Thoracic Society

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Abstract

Increasing awareness of cardiac manifestations of sarcoidosis and the widespread availability of advanced imaging tests have led to a tidal wave of interest in a condition that was once considered rare. In this Focused Review, we explore important clinical questions that may confront specialists faced with possible cardiac involvement. In the absence of an ideal reference standard, three main sets of clinical criteria exist: the Japanese Ministry of Health and Welfare, the Heart Rhythm Society, and the World Association for Sarcoidosis and Other Granulomatous Disorders criteria. Once cardiac sarcoidosis is suspected, clinicians should be familiar with the prevalence of the disease in different clinical scenarios. Before obtaining advanced cardiac imaging, electrocardiogram, ambulatory electrocardiogram, echocardiogram, and B-type natriuretic peptide may be useful. The available therapies for cardiac sarcoidosis include immunosuppression, antiarrhythmic medications, heart failure medications, device therapy, ablation therapy, and heart transplantation. Contemporary data suggest that long-term survival in cardiac sarcoidosis is better than previously believed. There is no randomized controlled trial demonstrating benefits of screening, but screening is recommended based on observational data.

Overview

Integrity signals

Registry

Crossref · 10.1513/annalsats.201902-119cme

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 2

  1. Kul, 2014, Diagnostic value of strain echocardiography, galectin-3, and tenascin-C levels for the identification of patients with pulmonary and cardiac sarcoidosis, Hai, 192, 533
  2. McCaffery, 2015, Recommendations about screening

Cited by

See all 63

Metadata

Authors
Ribeiro Neto, M. L., Jellis, C. L., Joyce, E., Callahan, T. D., Hachamovitch, R., & Culver, D. A.
Affiliations
  • Department of Pulmonary and Critical Care Medicine
  • Cleveland Clinic (US)
  • Mater Misericordiae University Hospital (IE)
Venue
Annals of the American Thoracic Society
Published
2019-11-01
Volume
16
Issue
11
Pages
1341-1350
ISSN
  • 2325-6621 (ISSN-L)
  • 2329-6933
OpenAlex
W2964101299
Cited by
63
References
77
Citations by year
2026: 3 · 2025: 7 · 2024: 8 · 2023: 18 · 2022: 11 · 2021: 10 · 2020: 4 · 2019: 2
FWCI
4.58
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of the American Thoracic Society (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Sarcoidosis and Beryllium Toxicity Research
  • Health Sciences › Medicine › Hematology › Histiocytic Disorders and Treatments
  • Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
Keywords
cardiac sarcoidosis, clinical criteria, cardiac imaging, electrocardiogram, echocardiography, brain natriuretic peptide, immunosuppressive therapy, antiarrhythmic therapy, heart failure medications, cardiac device therapy, ablation therapy, heart transplantation, long-term survival, screening
MeSH terms
Electrocardiography, Glucocorticoids, Heart, Humans, Immunosuppressive Agents, Cardiomyopathies, Pacemaker, Artificial, Sarcoidosis, Biomarkers, Heart Transplantation, Catheter Ablation, Defibrillators, Implantable, Tachycardia, Ventricular, Cardiac Imaging Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.